A comprehensive understanding of potential material change can mitigate its impact on patient safety.
Andrew Feilden
Advertisement
Andrew Feilden is the European E&L strategic director for Element.
Articles by Andrew Feilden
By understanding potential material change, the impact on patient safety can be understood and mitigated.
Advertisement
Latest Updated Articles
- The Impact of Material Management on Extractables and Leachables
Published: August 3rd 2022 | Updated:
Material Management and the Impact on Extractables and LeachablesPublished: July 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
